Details
Gregory Irwin is Senior Vice President of Corporate Development at Hut 8 Mining. He is a graduate of the University of Massachusetts Boston and holds an MBA from Boston University.
Work Experience
Education Experience
Relevance Person
Alejandro E Lopez
Alejandro E Lopez is Chief of Operations at Hut 8 Mining. He graduated from Boston University.
Sean Glennan
Sean Glennan is the Chief Financial Officer of Hut 8 Mining and was previously a Managing Director at Citibank. He is a graduate of the University of Notre Dame.
Giuseppe Stuto
Giuseppe Stuto is the Co-Founder & Managing Partner at 186 Ventures. Board Member at Integrated Projects. Advisor at Ponto, Reggora and Techstars. Giuseppe Stuto graduated from Questrom School of Business, Boston University.
Chung-Hsun Chang Chien
Chung-Hsun Chang Chien is principal analyst at Sharding Capital and previously a researcher at Red Building Capital. He graduated from Boston University and National Taipei University.
Ahmet Ozcan
Ahmet Ozcan is the co-founder and CEO of Odos and previously worked at IBM. He has a PhD from Boston University.
Justin Bram
Justin Bram is the Co-Founder & CEO at Astaria.Presively,he worked at Brink, Ondo Finance and Snap Inc.Justin Bram graduated from Boston University and University of Southern California - Marshall School of Business.
Jaime Leverton
Jaime Leverton is CEO of Ulys and was previously the CEO of Hut 8. He was formerly the Chief Commercial Officer and Senior Vice President at eStruxture Data Centers.
Carolyn Reckhow
Carolyn Reckhow is the chief operating officer of Thesis and is also responsible for Keep Project, tBTC and other projects. Previously, she worked at Casa, ConsenSys.
Daniel Kim
Daniel Kim is co-founder of Volta Wallet and Investment Director at FBG Capital. He graduated from Boston University.
Patrick Joyce
Patrick Joyce is the co-founder and COO of ResearchHub and the founder of Knowledgr, a medical student dedicated to breaking down barriers to participation in the scientific community. In particular, he hopes to revolutionize the understanding of human biology and lead to incredible clinical applications.